Walsh Deina H Insider Trades

Insider Trading History

Track insider trading activity for Walsh Deina H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $117k 8,335 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 8,335 shares
$14.70
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $10.3k 8,335 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.9k 8,335 shares
$1.55
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $379k 27,055 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.61M 27,055 shares
$355.20
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $33.5k 27,055 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.2k 27,055 shares
$0.97
$1.24
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $15.5k 12,500 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.1k 12,500 shares
$3.61
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $175k 12,500 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 12,500 shares
$28.20
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $18.6k 15,000 shares
Last Trade
Sep 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.4k 8,000 shares
$5.30
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $210k 15,000 shares
Last Trade
Sep 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$408k 8,000 shares
$51.00
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $8.68k 7,000 shares
Last Trade
Sep 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.5k 7,000 shares
$5.79
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $98k 7,000 shares
Last Trade
Sep 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$210k 7,000 shares
$30.00
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $54.4k 43,875 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$791k 18,875 shares
$41.92
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $614k 43,875 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.53k 18,875 shares
$0.24
$14.00
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $350k 25,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$0 25,000 shares
$0.00
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $31k 25,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8M 25,000 shares
$432.43
$1.24
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $49k 39,530 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $553k 39,530 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $155k 11,104 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $13.8k 11,104 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $6.52M 465,795 shares
Last Trade
Dec 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $578k 465,795 shares
Last Trade
Dec 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up